​

Edgewise Therapeutics Ownership | Who Owns Edgewise Therapeutics?

OverviewForecastFinancialsChart

Edgewise Therapeutics Ownership Summary

Edgewise Therapeutics is owned by 11.04% institutional investors, 0.45% insiders, and 88.51% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.49% of EWTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.70% of its assets in Edgewise Therapeutics shares.

EWTX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEdgewise Therapeutics11.04%0.45%88.51%
SectorHealthcare Stocks 35.56%12.08%52.36%
IndustryBiotech Stocks 35.43%12.01%52.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Orbimed advisors15.52M14.49%$630.52M
Paradigm biocapital advisors lp10.22M9.54%$415.05M
Ra capital management8.39M7.84%$341.00M
Blackrock6.02M6.87%$108.34M
Blackrock funding, inc. /de6.61M6.17%$268.42M
Janus henderson group5.92M5.75%$186.29M
Fmr5.49M5.12%$223.02M
Novo5.35M4.99%$217.37M
Vanguard group4.87M4.62%$120.89M
Driehaus capital management4.73M4.41%$192.12M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
New leaf venture partners1.03M38.82%$16.71M
Novo5.35M12.62%$217.37M
Orbimed advisors15.52M11.75%$630.52M
Paradigm biocapital advisors lp10.22M7.77%$415.05M
Tyro capital management612.97K5.59%$24.90M
Cormorant asset management, lp2.51M5.23%$101.98M
Bioimpact capital1.62M4.02%$65.85M
Integral health asset management2.00M3.21%$81.26M
Braidwell lp2.00M3.00%$81.14M
Ally bridge group (ny)83.30K2.99%$3.38M

Top Buyers

HolderShares% AssetsChange
Fmr5.49M0.01%4.47M
Paradigm biocapital advisors lp10.22M7.77%2.85M
Janus henderson group5.92M0.09%1.35M
Blackrock6.02M0.00%848.71K
Price t rowe associates inc /md/816.52K0.00%747.09K

Top Sellers

HolderShares% AssetsChange
Baker bros. advisors lp3.70M0.75%-2.87M
Tcg crossover management---2.11M
Ra capital management8.39M2.96%-2.04M
Bellevue group---1.53M
Deep track capital, lp---1.40M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company620.53K0.00%620.53K$25.21M
Tyro capital management612.97K5.59%612.97K$24.90M
Norges bank510.14K0.00%510.14K$20.73M
Adage capital partners gp462.00K0.03%462.00K$18.77M
Point72 asset management117.26K0.01%117.26K$4.76M

Sold Out

HolderChange
American national bank-2.00
Quadrant capital group-6.00
Creekmur asset management-8.00
Nelson, van denburg & campbell wealth management group-8.00
Mai capital management-9.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202679-62.38%11,359,426-90.68%110.08%40-65.52%19-66.67%
Dec 31, 2025109-39.11%34,717,234-68.99%320.29%62-23.46%26-57.38%
Sep 30, 20251761.15%111,963,848-3.66%1060.87%78-31.58%6160.53%
Jun 30, 2025182-15.35%118,716,11213.87%1130.94%11813.46%39-40.00%
Mar 31, 20252141.42%105,276,5966.36%1100.99%104-14.05%635.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv2.90M2.70%-1.62K
Vanguard Morn Total Stk Mkt Idx Investor2.90M2.70%-1.62K
Vanguard US Total Market Shares ETF2.54M2.67%-5.23K
BB Biotech AG Ord2.78M2.62%-
Strategic Advisers Fidelity US TtlStk2.81M2.59%871.38K
iShares Russell 2000 ETF1.81M1.66%-32.06K
Polar Capital Biotech S Inc975.00K0.93%-
Artisan International Small-Mid Investor914.19K0.87%281.23K
Artisan Non-U.S. Small-Mid Growth Comp914.19K0.87%281.23K
Vanguard Institutional Extnd Mkt Idx Tr864.42K0.80%25.39K

Recent Insider Transactions

DateNameRoleActivityValue
Aug 12, 2026Donovan Joanne M. CMOSell$4.62K
Aug 12, 2026Donovan Joanne M. CMOSell$35.61K
Aug 12, 2026Donovan Joanne M. CMOSell$121.46K
Aug 12, 2026Donovan Joanne M. CMOSell$124.30K
Aug 13, 2026Donovan Joanne M. CMOSell$126.70K

Insider Transactions Trends

DateBuySell
2026 Q3-21
2026 Q2-3
2026 Q1-8
2025 Q411
2025 Q3-7

EWTX Ownership FAQ

Who Owns Edgewise Therapeutics?

Edgewise Therapeutics shareholders are primarily institutional investors at 11.04%, followed by 0.45% insiders and 88.51% retail investors. The average institutional ownership in Edgewise Therapeutics's industry, Biotech Stocks , is 35.43%, which Edgewise Therapeutics falls below.

Who owns the most shares of Edgewise Therapeutics?

Edgewise Therapeutics’s largest shareholders are Orbimed advisors (15.52M shares, 14.49%), Paradigm biocapital advisors lp (10.22M shares, 9.54%), and Ra capital management (8.39M shares, 7.84%). Together, they hold 31.86% of Edgewise Therapeutics’s total shares outstanding.

Does Blackrock own Edgewise Therapeutics?

Yes, BlackRock owns 6.87% of Edgewise Therapeutics, totaling 6.02M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 108.34M$. In the last quarter, BlackRock increased its holdings by 848.7K shares, a 16.43% change.

Who is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Edgewise Therapeutics’s biggest shareholder by percentage of total assets invested, with 38.82% of its assets in 1.03M Edgewise Therapeutics shares, valued at 16.71M$.

Who is the top mutual fund holder of Edgewise Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Edgewise Therapeutics shares, with 2.70% of its total shares outstanding invested in 2.9M Edgewise Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools